ScholarIQanswers from OpenAlex
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
PaperCitations, authors & open-access status
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes have?
ScholarIQcitation count
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes has 1,969 citations in the OpenAlex counts ScholarIQ stores.
When was Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes published?
ScholarIQyear
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes has 2019 year in the ScholarIQ index.
What is the open-access status of Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
ScholarIQoa status
Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes has bronze oa status in the ScholarIQ index.
What is the DOI of Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
ScholarIQdoi
The DOI for Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is on the source record.
What is the OpenAlex record for Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes?
ScholarIQopenalex
The OpenAlex for Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes is on the source record.